Standard
Atherogenic Dyslipidemia and Residual Cardiovascular Risk in Statin-Treated Patients. / Sillesen, Henrik; PERFORM and SPARCL Investigators and Committee.
In:
Stroke, Vol. 45, No. 5, 05.2014, p. 1429-1436.
Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
Sillesen, H & PERFORM and SPARCL Investigators and Committee 2014, '
Atherogenic Dyslipidemia and Residual Cardiovascular Risk in Statin-Treated Patients',
Stroke, vol. 45, no. 5, pp. 1429-1436.
https://doi.org/10.1161/STROKEAHA.113.004229
APA
Sillesen, H., & PERFORM and SPARCL Investigators and Committee (2014).
Atherogenic Dyslipidemia and Residual Cardiovascular Risk in Statin-Treated Patients.
Stroke,
45(5), 1429-1436.
https://doi.org/10.1161/STROKEAHA.113.004229
Vancouver
Sillesen H, PERFORM and SPARCL Investigators and Committee.
Atherogenic Dyslipidemia and Residual Cardiovascular Risk in Statin-Treated Patients.
Stroke. 2014 May;45(5):1429-1436.
https://doi.org/10.1161/STROKEAHA.113.004229
Author
Sillesen, Henrik ; PERFORM and SPARCL Investigators and Committee. / Atherogenic Dyslipidemia and Residual Cardiovascular Risk in Statin-Treated Patients. In: Stroke. 2014 ; Vol. 45, No. 5. pp. 1429-1436.
Bibtex
@article{7bc5819409fe4ccb865fa713ef7bd9fb,
title = "Atherogenic Dyslipidemia and Residual Cardiovascular Risk in Statin-Treated Patients",
keywords = "cardiovascular diseases, HMG-CoA reductase inhibitors, lipids, stroke",
author = "Gaia Sirimarco and Julien Labreuche and Eric Bruckert and Goldstein, {Larry B.} and Fox, {Kim M.} and Rothwell, {Peter M.} and Pierre Amarenco and Henrik Sillesen and {PERFORM and SPARCL Investigators and Committee}",
year = "2014",
month = may,
doi = "10.1161/STROKEAHA.113.004229",
language = "English",
volume = "45",
pages = "1429--1436",
journal = "Stroke",
issn = "0039-2499",
publisher = "Lippincott Williams & Wilkins",
number = "5",
}
RIS
TY - JOUR
T1 - Atherogenic Dyslipidemia and Residual Cardiovascular Risk in Statin-Treated Patients
AU - Sirimarco, Gaia
AU - Labreuche, Julien
AU - Bruckert, Eric
AU - Goldstein, Larry B.
AU - Fox, Kim M.
AU - Rothwell, Peter M.
AU - Amarenco, Pierre
AU - Sillesen, Henrik
AU - PERFORM and SPARCL Investigators and Committee
PY - 2014/5
Y1 - 2014/5
KW - cardiovascular diseases
KW - HMG-CoA reductase inhibitors
KW - lipids
KW - stroke
U2 - 10.1161/STROKEAHA.113.004229
DO - 10.1161/STROKEAHA.113.004229
M3 - Journal article
C2 - 24736236
VL - 45
SP - 1429
EP - 1436
JO - Stroke
JF - Stroke
SN - 0039-2499
IS - 5
ER -
